Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy

Kidney Int. 1998 Oct;54(4):1390-1. doi: 10.1046/j.1523-1755.1998.00127.x.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Animals
  • Diabetic Nephropathies / pathology
  • Diabetic Nephropathies / physiopathology*
  • Diabetic Nephropathies / therapy*
  • Fibrosis
  • Humans
  • Renin-Angiotensin System / physiology
  • Transforming Growth Factor beta / antagonists & inhibitors
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / physiology*

Substances

  • Transforming Growth Factor beta